Lastly, a significant limitation is the context-dependent duality of GPR65, functioning as potentially tumor-suppressive in some contexts (like our findings in LUAD and reports in hematologic malignancies) while appearing oncogenic in others (e.g., colon, ovarian, kidney cancers). The gene discussed is GPR65; the disease is kidney cancer.